pyrrolo<4,3,2-de>-quinoline-7,8-dione | 157669-64-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: pyrrolo<4,3,2-de>-quinoline-7,8-dione
• 英文别名: 2,7-diazatricyclo[6.3.1.04,12]dodeca-1(12),3,8-triene-10,11-dione
• CAS: 157669-64-2
• 化学式: C₁₀H₈N₂O₂
• mdl: MFCD20542942
• 分子量: 188.186
• InChiKey: KYPUUOLJPNAIDV-UHFFFAOYSA-N

物化性质

• 熔点：
  154-156 °C
• 沸点：
  526.2±50.0 °C(Predicted)
• 密度：
  1.50±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.29
• 重原子数：
  14.0
• 可旋转键数：
  0.0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  61.96
• 氢给体数：
  2.0
• 氢受体数：
  3.0

反应信息

• 作为反应物：
  描述：

  pyrrolo<4,3,2-de>-quinoline-7,8-dione 在 氢氧化钾 、 氨 作用下， 以 甲醇 为溶剂， 生成 makaluvamine I
  参考文献：
  名称：

  吡咯烷氨基醌及其促红素原连接衍生物的便捷合成

  摘要：

  描述了设计用于改善细胞摄取的1-4，吡咯烷氨基醌生色团及其与促红细胞素载体连接的衍生物的合成。

  DOI：

  10.1016/s0040-4039(00)73118-2
• 作为产物：
  描述：

  6,7-Dibenzyloxy-indol-3-glyoxylamid 在 钯 barium sulfate 、 lithium aluminium tetrahydride 、 氢气 、 三乙胺 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 生成 pyrrolo<4,3,2-de>-quinoline-7,8-dione
  参考文献：
  名称：

  吡咯烷氨基醌及其促红素原连接衍生物的便捷合成

  摘要：

  描述了设计用于改善细胞摄取的1-4，吡咯烷氨基醌生色团及其与促红细胞素载体连接的衍生物的合成。

  DOI：

  10.1016/s0040-4039(00)73118-2

文献信息

• Synthesis of Tetrahydropyrroloiminoquinone Alkaloids Based on Electrochemically Generated Hypervalent Iodine Oxidative Cyclization
  作者：Keisuke Inoue、Yuichi Ishikawa、Shigeru Nishiyama

  DOI：10.1021/ol902566p

  日期：2010.2.5

  of N-1-β-d-ribofuranosyltetrahydropyrroloiminoquinones. The strategy utilizes oxidative cyclization of aryl-methoxyamides by hypervalent iodine to construct the quinoline framework shared by members of this alkaloid family. The hypervalent iodine oxidant is generated in situ by anodic oxidation of iodobenzene.

  已经开发出一种合成四氢吡咯并亚氨基醌生物碱的方法，并将其用于制备N -1-β- d-核呋喃糖基四氢吡咯并亚氨基醌。该策略利用高价碘对芳基-甲氧基酰胺进行氧化环化，以构建该生物碱家族成员共有的喹啉骨架。高价碘氧化剂是通过碘苯的阳极氧化原位产生的。
• [EN] PYRROLOQUINOLIN COMPOUNDS AND METHODS OF USING SAME<br/>[FR] COMPOSÉS DE PYRROLOQUINOLÉINE ET LEURS MÉTHODES D'UTILISATION
  申请人：UNIV CALIFORNIA

  公开号：WO2018170019A1

  公开（公告）日：2018-09-20

  Provided are pyrroloquinolin compounds of formula (1) or (II). In certain aspects, the pyrroloquinolin compounds are therapeutic, e.g., for treating a cell proliferative disorder. Also provided are conjugates that include the pyrroloquinolin compounds of the present disclosure. Compositions, e.g., pharmaceutical compositions, that include the pyrroloquinolin compounds and conjugates of the present disclosure are also provided. Further provided are therapeutic methods involving the administration of the pyrroloquinolin compounds, conjugates or compositions of the present disclosure. Kits that include the pyrroloquinolin compounds, conjugates or compositions are also provided. Formula (I), (II).

  提供了式（I）或（II）的吡咯喹啉化合物。在某些方面，这些吡咯喹啉化合物具有治疗作用，例如用于治疗细胞增殖性疾病。还提供了包括本公开的吡咯喹啉化合物的结合物。还提供了包括本公开的吡咯喹啉化合物和结合物的组成物，例如制药组成物。还提供了涉及给予本公开的吡咯喹啉化合物、结合物或组成物的治疗方法。还提供了包括吡咯喹啉化合物、结合物或组成物的试剂盒。式（I），（II）。
• Pyrroloquinolin compounds and methods of using same
  申请人：The Regents of the University of California

  公开号：US11020488B2

  公开（公告）日：2021-06-01

  Provided are pyrroloquinolin compounds of formula (1) or (II). In certain aspects, the pyrroloquinolin compounds are therapeutic, e.g., for treating a cell proliferative disorder. Also provided are conjugates that include the pyrroloquinolin compounds of the present disclosure. Compositions, e.g., pharmaceutical compositions, that include the pyrroloquinolin compounds and conjugates of the present disclosure are also provided. Further provided are therapeutic methods involving the administration of the pyrroloquinolin compounds, conjugates or compositions of the present disclosure. Kits that include the pyrroloquinolin compounds, conjugates or compositions are also provided.

  所提供的是式(1)或(II)的吡咯喹啉化合物。在某些方面，这些吡咯喹啉化合物具有治疗作用，例如用于治疗细胞增殖性疾病。还提供了包括本公开的吡咯喹啉化合物的共轭物。还提供了包括本公开的吡咯喹啉化合物和共轭物的组合物，例如药物组合物。此外，还提供了涉及施用本公开的吡咯喹啉化合物、共轭物或组合物的治疗方法。还提供了包括吡咯喹啉化合物、共轭物或组合物的试剂盒。
• PYRROLOQUINOLIN COMPOUNDS AND METHODS OF USING SAME
  申请人：The Regents of the University of California

  公开号：US20200129631A1

  公开（公告）日：2020-04-30

  Provided are pyrroloquinolin compounds of formula (1) or (II). In certain aspects, the pyrroloquinolin compounds are therapeutic, e.g., for treating a cell proliferative disorder. Also provided are conjugates that include the pyrroloquinolin compounds of the present disclosure. Compositions, e.g., pharmaceutical compositions, that include the pyrroloquinolin compounds and conjugates of the present disclosure are also provided. Further provided are therapeutic methods involving the administration of the pyrroloquinolin compounds, conjugates or compositions of the present disclosure. Kits that include the pyrroloquinolin compounds, conjugates or compositions are also provided.
• Convenient syntheses of pyrroloiminoquinone and its lexitropsin-linked derivative
  作者：Huiying Wang、Naim H. Al-Said、J.William Lown

  DOI：10.1016/s0040-4039(00)73118-2

  日期：1994.6

  The syntheses of 1–4, pyrroloiminoquinone chromophore and its lexitropsin carrier linked derivative designed to improved cellular uptake are described.

  描述了设计用于改善细胞摄取的1-4，吡咯烷氨基醌生色团及其与促红细胞素载体连接的衍生物的合成。

表征谱图